BMY
BRISTOL-MYER SQB
Health Care·Pharmaceuticals·UNITED STATES
$66.82
MCap $136.5B
as of 2026-09-04
Total
B5w
Fund
C10w
Quant
A2w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-09-04
MIDOS SI
-0.64
Sentiment 84.3%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$66.82
Adaptive Mean
$67.67
-0.85 vs mean
Adaptive σ
0.67
MIDOS BB
$66.34 – $69.01
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-09-04
Composite Z
+0.16
ROE
46.6%
Z +0.90
Rev Gr
5.7%
Z -0.28
EPS Gr
153.1%
Z +0.04
OPM Gr
0.3%
Z -0.38
FCF Yld
5.9%
Z +0.67
EPS Surp
0.3%
Z +0.03
EPS 3mo Δ
6.3%
Z +0.15
Fwd P/E
10.19
Z —
PEGY
0.02
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-09-04
Q3M
12.75
Q6M
3.74
Q12M
7.88
MA 30/100
1.093
Bullish (MA30 > MA100)
α (Jensen)
0.5973
β (12M)
0.27
σ (12M)
0.274
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
76%
Q Percentile
92%
Divergence
-16.6
Tier
TRIM — WATCH
Momentum ahead of fundamentals.
Kirkpatrick RS & Persistence
RS
-3.0
RS Pctl
56%
RS Decile
D6
Persistence
5w
at grade B
Options / OI Analysis
No options or Williams data available for this ticker.